Skip to main content

Find Clinical Trials

Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Recruiting

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

NCT04561557

Conditions: Abnormalities, Multiple, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +45 more
Locations: Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma

NCT06659276

Conditions: Behavior, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations: Policlinico S.Orsola Malpighi Bologna, Italy

View Trial Details

Recruiting

LMY-920 for Treatment of Relapsed or Refractory Myeloma

NCT05546723

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University Hospitals Seidman Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma

NCT06183489

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Helsinki University Hospital Helsinki, Finland

CHD Vendée La Roche-sur-Yon, France

CHRU de Lille - Hopital Claude Huriez Lille, France

CHU Saint Eloi Département d'Hématologie Clinique Montpellier, France

View all 25 locations

View Trial Details

Recruiting

A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma

NCT05299424

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Peking University Third Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Two Schemes Response in Multiple Myeloma

NCT06284395

Conditions: Acute-Phase Reaction, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Hospital General de Mexico Dr. Eduardo Liceaga Mexico City, Mexico

View Trial Details

Recruiting

Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma

NCT06581640

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

NCT06539832

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Gut Microbiota, +16 more
Locations: Zhujiang Hospital of Southern Medical University Guanzhou, Guangdong, China

View Trial Details

Recruiting

Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM

NCT05914662

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)

NCT06187441

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands

NL-Almere-FLEVOZIEKENHUIS Almere Stad, Netherlands

NL-Amersfoort-MEANDERMC Amersfoort, Netherlands

NL-Amsterdam- UMC Amsterdam, Netherlands

View all 38 locations

View Trial Details